Advisory Board

NeuroVive has a clinical and scientific advisory board whose members have extensive experience and unique know-how in the treatment of brain-injured patients, as well as in the design of clinical trials.

Per-Olof Grände

Per-Olof Grände is a physician and professor. He is head of the department of anaesthesiology and intensive care at Lund University Hospital, and has been awarded a number of honours for his innovative research. In conjunction with Carl-Henrik Nordström, he produced what is now known as the Lund Concept that aims to prevent brain swelling in cases of traumatic brain injury following, for example, road accidents and falls. This model is used in intensive care both in Sweden and abroad. He has also published some 85 scientific papers.

Andrew Maas

Andrew Maas is a neurosurgeon and professor at the University Hospital at Antwerp, Belgium. He continues to be involved in many committees and organizations in the areas of intensive care and brain damage. Maas is regarded internationally as being a leading specialist in design and interpretation of clinical studies of traumatic brain damage. He has also been involved in organizing a number of scientific conferences on the topic of traumatic brain damage.

Carl-Henrik Nordström

Carl-Henrik Nordström is a neurosurgeon, professor and consultant at Lund University and Lund University Hospital. He designed the Lund concept mentioned above, together with Per-Olof Grände; he has also been involved in developing a method using cerebral microdialysis to evaluate new treatment principles in patients with serious cranial damage. Professor Nordström has won many prizes for his research work and is often invited as guest speaker at conferences and universities all over the world. He has authored and co-authored some two hundred scientific publications on neurointensive care and other subjects.

Bertil Romner

Bertil Romner is a professor at the Rigshospital at Copenhagen University. From 1985 to 2006, he was a neurosurgeon at Lund University Hospital, where he also lectured. He has published more than 80 papers and given presentations at many conferences on the subject of the brain, brain injury, and other neurological topics.

Håkan Widner

Håkan Widner is a professor, consultant and clinical manager at Lund University Hospital. He continues to be an active member of many pharmaceutical companies’ advisory boards and has given presentations at a large number of international conferences. Professor Widner was one of the people behind the original patent to protect nerve cells using cyclosporine-A, and has won many awards for his innovative clinical research. He is also a partner in NeuroVive via Maas Biolab, LLC.